/Investor DB

1/1 Capital — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

AgelessRxagelessrx.comin𝕏Jan 2026

AgelessRx offers prescription weight management medications delivered through a telehealth platform, including GLP-1 medications (semaglutide, tirzepatide), FDA-approved weight loss drugs (Wegovy, Zepbound), and supportive treatments like metformin and vitamin injections for adults seeking medically-supervised weight loss.

BiotechDigital HealthDirect to ConsumerHealthtechLongevityAnn Arbor, US

Anar Isman(Co-Founder & Chief Executive Officer)inRobert Michael Pejovich(Director of Finance of the Issuer)

Co-investorsabrdn plcAngelini VenturesFidelity InvestmentsJanus Henderson InvestorsSanofi Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.